首页> 外文期刊>Ophthalmic Surgery and Lasers >Combined cataract surgery and vitrectomy for breakthrough vitreous hemorrhage from age-related macular degeneration.
【24h】

Combined cataract surgery and vitrectomy for breakthrough vitreous hemorrhage from age-related macular degeneration.

机译:白内障手术和玻璃体切除术相结合,可解决因年龄相关性黄斑变性引起的玻璃体出血。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To report combined cataract extraction (CE), posterior chamber intraocular lens (PCIOL) implantation, and pars plana vitrectomy (PPV) for concurrent cataract and breakthrough vitreous hemorrhage from age-related macular degeneration (AMD). METHODS: Retrospective case series. RESULTS: Six eyes were included in the study. The postoperative follow-up interval ranged from 3 to 22 months (mean 8 months). Preoperative visual acuity (VA) ranged from 20/400 to hand motion. Postoperatively, 5/6 eyes had 2 or more lines of visual improvement. Three eyes were better than 20/200. CONCLUSIONS: Combined CE, PCIOL insertion, and PPV in selected patients with cataract and breakthrough vitreous hemorrhage from AMD was successful in improving VA in the majority of patients.
机译:目的:报告联合白内障摘除术(CE),后房人工晶状体植入术(PCIOL)和pars平面玻璃体切除术(PPV)用于并发白内障和年龄相关性黄斑变性(AMD)引起的玻璃体出血。方法:回顾性病例系列。结果:该研究包括六只眼。术后随访时间为3到22个月(平均8个月)。术前视力(VA)为20/400至手部运动。术后5/6眼有2条或2条以上的视线改善。三只眼好于20/200。结论:CE,PCIOL插入和PPV联合治疗对部分白内障和AMD突破性玻璃体出血的患者成功改善了大多数患者的视力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号